SEC ownership of Insight Molecular Diagnostics Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001642380.

Comparable stake leader

BROADWOOD PARTNERS, L.P.

Disclosed value leader

BROADWOOD PARTNERS, L.P.

Comparable rows

44/50

Latest evidence

01 Jul 2026

Top shareholders Insider holders Latest transactions
Public ticker
IMDX on Nasdaq
Parsed ownership sources
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder
BROADWOOD PARTNERS, L.P.
Ranking: Comparable ownership first, then disclosed value
Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
44 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BROADWOOD PARTNERS, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
01 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001642380
Issuer location
Nashville, TN

Ownership snapshot

Top shareholders of Insight Molecular Diagnostics Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD PARTNERS, L.P.
Disclosed value leader
BROADWOOD PARTNERS, L.P.
Comparable rows
44/50
Latest evidence
01 Jul 2026
3/4/5 13D/G 13F Lead comparable stake: 40% 6 rows are not safely comparable across share classes. 13D/G row: BROADWOOD PARTNERS, L.P. Showing 1-8 of 50 holder rows.

Quick read

BROADWOOD PARTNERS, L.P. leads the comparable SEC ownership view at 40%.

44 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD PARTNERS, L.P.'s linked filing trail.
Comparable ownership Top 5
BROADWOOD PARTNERS, L.P. 40%
Patrick W. Smith 10%
AWM Investment Company, Inc. 10%
BIO-RAD LABORATORIES, INC. 9.7%
BROADWOOD CAPITAL INC 37%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD PARTNERS, L.P.
3/4/5 13D/G
10%+ Owner · Neal C. Bradsher
3/4/5 13D/G
40%
from 13D/G
$88,478,605
25,669,954 shares
mixed-class rows
 +$5,685,126 23 Apr 2026
Patrick W. Smith
3/4/5 13D/G
10%+ Owner
3/4/5 13D/G
10%
from 13D/G
$6,679,894
3,258,485 shares
 — 07 Feb 2025
AWM Investment Company, Inc.
13D/G 13F
Company
13D/G 13F
10%
$9,685,464
2,857,069 shares
 +$5,257,076 31 Mar 2025
BIO-RAD LABORATORIES, INC.
13D/G
13D/G
9.7%
$608,097
2,764,078 shares
 $0 10 Feb 2025
BROADWOOD CAPITAL INC
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
37%
from 13F
$88,478,605
25,669,954 shares
mixed-class rows
 +$2,685,127 23 Apr 2026
PURA VIDA INVESTMENTS, LLC
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
2.9%
$3,106,600
947,134 shares
 — 31 Mar 2026
Alyeska Investment Group, L.P.
13F
Company
13F
2.6%
$2,757,749
840,777 shares
 — 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
1.7%
$1,761,888
537,161 shares
 — 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$11,055,380.

Buys
$11,055,380
Insiders: 3
Sells
$0
Insiders: 0
Net
+$11,055,380
Shares: +2,780,874
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 2,780,874 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 2,259,135 0 $8,055,381 $0 +$8,055,381
3-6 521,739 0 $2,999,999 $0 +$2,999,999
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 23 reporting-owner rows connected to Insight Molecular Diagnostics Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
23
Largest Forms 3/4/5 holder
BROADWOOD CAPITAL INC
Net 12M change
+$11,055,380
Latest report
01 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
BROADWOOD CAPITAL INC 10%+ Owner $88,478,605 +$2,685,127 +3.1% Mixed 23 Apr 2026
BROADWOOD PARTNERS, L.P. 10%+ Owner $88,478,605 +$5,685,126 +6.9% Mixed 23 Apr 2026
Neal C. Bradsher 10%+ Owner $88,478,605 +$2,685,127 +3.1% Mixed 23 Apr 2026
Patrick W. Smith 10%+ Owner $6,679,894 Mixed 07 Feb 2025
PURA VIDA INVESTMENTS, LLC 10%+ Owner $3,044,309 Mixed 14 Apr 2023
Andrea S. James Chief Financial Officer $1,777,524 Mixed 26 Mar 2026
Josh Riggs CEO and President, Director $674,529 Mixed 26 Mar 2026
Andrew Arno Director $539,851 Mixed 01 Jul 2026
Andrew J. Last Director $192,706 Mixed 01 Jul 2026
Lou Silverman Director $183,046 Mixed 01 Jul 2026
John Peter Gutfreund Former Director $153,654 Mixed 30 Jun 2023
Ronald Asbury Andrews Former CEO, Director $125,332 Mixed 01 Dec 2022
Alfred D. Kingsley Director $109,143 Mixed 23 Jun 2023
Gisela Paulsen Former President and COO $78,761 Mixed 16 Dec 2022
Li Yu VP Cntrllr/Prncpl Acctng Offcr $76,536 Mixed 18 May 2022
James Yang Liu VP ACCT, Cntlr, Treasurer, PAO $66,509 Mixed 26 Mar 2026
Ross Douglas T. Former CSO $50,311 Mixed 21 Dec 2022
Cavan M. Redmond Director $25,973 Mixed 24 Jun 2022
Mitchell S. Levine Chief Financial Officer $18,713 Mixed 15 Mar 2022
Jennifer Levin Carter Director $6,554 Mixed 15 Aug 2022

Recent insider transactions for Insight Molecular Diagnostics Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Lou Silverman IMDX Common Stock, no par value Tax liability -12.1% -7,700 55,807 01 Jul 2026 Direct
Andrew J. Last IMDX Common Stock, no par value Tax liability -11.6% -7,700 58,752 01 Jul 2026 Direct
Andrew Arno IMDX Common Stock, no par value Tax liability -7.16% -12,100 156,785 01 Jul 2026 Direct
Lou Silverman IMDX Common Stock, no par value Award 73.7% 26,943 63,507 11 Jun 2026 Direct
Andrew J. Last IMDX Common Stock, no par value Award 68.2% 26,943 66,452 11 Jun 2026 Direct
Andrew Arno IMDX Common Stock, no par value Award 23.7% 32,331 168,885 11 Jun 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,684,884 27 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,684,884 27 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,684,884 27 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 2.02% $913,134 $3.64 250,923 12,684,884 27 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 2.02% $913,134 $3.64 250,923 12,684,884 27 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 2.02% $913,134 $3.64 250,923 12,684,884 27 Apr 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,433,961 24 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,433,961 24 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,433,961 24 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0.31% $137,083 $3.53 38,880 12,433,961 24 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.31% $137,083 $3.53 38,880 12,433,961 24 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.31% $137,083 $3.53 38,880 12,433,961 24 Apr 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,395,081 23 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,395,081 23 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,395,081 23 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 2.31% $982,034 $3.50 280,381 12,395,081 23 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 2.31% $982,034 $3.50 280,381 12,395,081 23 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 2.31% $982,034 $3.50 280,381 12,395,081 23 Apr 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,114,700 20 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,114,700 20 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,114,700 20 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0.34% $157,967 $3.88 40,690 12,114,700 20 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.34% $157,967 $3.88 40,690 12,114,700 20 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.34% $157,967 $3.88 40,690 12,114,700 20 Apr 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,074,010 17 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,074,010 17 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,074,010 17 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0.33% $143,251 $3.57 40,114 12,074,010 17 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.33% $143,251 $3.57 40,114 12,074,010 17 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.33% $143,251 $3.57 40,114 12,074,010 17 Apr 2026 Direct
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0 12,033,896 16 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,033,896 16 Apr 2026 Footnote
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0 12,033,896 16 Apr 2026 Footnote
BROADWOOD PARTNERS, L.P. IMDX Common Stock, no par value Purchase 0.86% $351,658 $3.45 102,057 12,033,896 16 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.86% $351,658 $3.45 102,057 12,033,896 16 Apr 2026 Direct
Broadwood Partners, L.P. IMDX Common Stock, no par value Purchase 0.86% $351,658 $3.45 102,057 12,033,896 16 Apr 2026 Direct
Andrea S. James IMDX Common Stock Tax liability -5.2% -11,298 206,060 26 Mar 2026 Direct
Andrea S. James IMDX Common Stock Options Exercise 15% 28,302 217,358 26 Mar 2026 Direct
Andrea S. James IMDX Restricted Stock Units Options Exercise -25% -28,302 84,905 26 Mar 2026 Direct
James Yang Liu IMDX Common Stock Tax liability -41% -2,578 3,711 26 Mar 2026 Direct
James Yang Liu IMDX Common Stock Options Exercise 6,289 6,289 26 Mar 2026 Direct
James Yang Liu IMDX Restricted Stock Units Options Exercise -33.3% -6,289 12,578 26 Mar 2026 Direct
Josh Riggs IMDX Common Stock Tax liability -24.3% -12,310 38,365 26 Mar 2026 Direct
Josh Riggs IMDX Common Stock Options Exercise 1345.8% 47,170 50,675 26 Mar 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .